TABLE 2.

Enrichment analysis of differentially expressed IRGs in kainite-induced epilepsy.

Ontology	ID	Description	GeneRatio	BgRatio	P-value	p.adjust	q-value
BP	GO:0050900	Leukocyte migration	15/34	340/23,210	3.25e−19	6.61e−16	2.83e−16
BP	GO:0032103	Positive regulation of response to external stimulus	14/34	312/23,210	5.14e−18	5.22e−15	2.23e−15
BP	GO:0030595	Leukocyte chemotaxis	12/34	211/23,210	1.07e−16	7.24e−14	3.10e−14
BP	GO:0097529	Myeloid leukocyte migration	11/34	207/23,210	5.20e−15	2.64e−12	1.13e−12
BP	GO:0060326	Cell Chemotaxis	12/34	299/23,210	7.14e−15	2.90e−12	1.24e−12
CC	GO:0045121	Membrane raft	7/34	364/2,3436	7.72e−07	2.34e−05	1.47e−05
CC	GO:0098857	Membrane microdomain	7/34	365/2,3436	7.86e−07	2.34e−05	1.47e−05
CC	GO:0098589	Membrane region	7/34	377/23,436	9.76e−07	2.34e−05	1.47e−05
CC	GO:0043235	Receptor complex	5/34	394/23,436	2.44e−04	0.003	0.002
CC	GO:0070062	Extracellular exosome	3/34	90/23,436	3.01e−04	0.003	0.002
MF	GO:0005125	Cytokine activity	12/34	215/22,710	1.74e−16	2.03e−14	1.02e−14
MF	GO:0048018	Receptor ligand activity	14/34	489/22,710	3.60e−15	2.10e−13	1.06e−13
MF	GO:0008009	Chemokine activity	6/34	44/22,710	4.79e−11	1.87e−09	9.41e−10
MF	GO:0001664	G protein-coupled receptor binding	9/34	293/22,710	3.46e−10	1.01e−08	5.10e−09
MF	GO:0042379	Chemokine receptor binding	6/34	67/22,710	6.61e−10	1.55e−08	7.79e−09
KEGG	mmu04668	TNF signaling pathway	10/33	113/8,910	5.21e−12	7.19e−10	4.22e−10
KEGG	mmu04657	IL-17 signaling pathway	9/33	91/8,910	2.55e−11	1.76e−09	1.03e−09
KEGG	mmu04620	Toll-like receptor signaling pathway	9/33	100/8,910	6.05e−11	2.29e−09	1.34e−09
KEGG	mmu04933	AGE-RAGE signaling pathway in diabetic complications	9/33	101/8,910	6.63e−11	2.29e−09	1.34e−09
KEGG	mmu05323	Rheumatoid arthritis	8/33	87/8,910	6.78e−10	1.87e−08	1.10e−08